Rationale: βARs (β-adrenergic receptors) are prototypical GPCRs (G protein-coupled receptors) that play a pivotal role in sympathetic regulation. In heart cells, β 1 AR signaling mediates a global response, including both l-type Ca 2+ channels in the sarcolemma/T tubules and RyRs (ryanodine receptors) in the SR (sarcoplasmic reticulum). In contrast, β 2 AR mediates local signaling with little effect on the function of SR proteins.
H eart contraction is controlled by transient increase of intracellular Ca
2+ concentration and is regulated by βARs (β-adrenergic receptors) and other signaling pathways. 1 In ventricular myocytes, a Ca 2+ transient is generated via the Ca 2+ -induced Ca 2+ release mechanism, 2 in which the Ca 2+ influx through l-type Ca 2+ channels (LCCs) in the sarcolemma and T tubules (TTs) triggers Ca 2+ release from RyRs (ryanodine receptors) in the SR (sarcoplasmic reticulum). 3, 4 During diastole, Ca 2+ is either retaken into the SR by the SERCA (sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPase) or removed from cells by Na + -Ca 2+ exchangers, 1 and SERCA activity is regulated by the phosphorylation status of phospholamban. 5 Acute βAR stimulation activates PKA (protein kinase A) -dependent phosphorylation of LCCs, RyRs, and phospholamban, thus upregulating the trigger Ca 2+ from LCC, the Ca 2+ sensitivity of RyRs, and the releasable amount of SR Ca 2+ retaken by SERCA. [5] [6] [7] [8] By increasing beat-to-beat Ca 2+ transients via these mechanisms, βAR signaling mediates the sympathetic regulation of cardiac excitation-contraction coupling.
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Meet the First Author, see p 1278 β 1 AR and β 2 ARs are the major subtypes of βARs expressed in heart cells. 9 However, their exact roles are distinct because of the different spatial and temporal spans of cAMP-PKA signaling. 6, 10 Upon global cAMP elevation, β 1 ARs mediate the upregulation of LCCs, RyRs, and SERCAs, inducing positive inotropy and lusitropy. [5] [6] [7] [8] In contrast, although β 2 AR stimulation also increases LCC currents (but not in mouse cardiomyocytes 11 ) via the cAMP pathway, 11 this occurrence is uncoupled from the phosphorylation of many cytosolic proteins, including phospholamban, myosin binding protein C, and troponin I. 9, 12 Several mechanisms have been postulated to explain the inability of β 2 AR to modulate cytosolic proteins, including (1) β 2 AR is coupled to both G s (stimulatory G protein) and G i (inhibitory G protein) pathways 13, 14 ; (2) β 2 ARs are spatially confined within caveolae or caveolin-3-enriched membrane compartments 15, 16 ; and (3) the spatial diffusion of β 2 AR-activated cAMP is restricted by PDEs (phosphodiesterases). [17] [18] [19] Intuitively, β 2 AR signaling appears to be a castrated version of β 1 AR signaling in terms of excitation-contraction regulation. However, accumulating evidence in pathological and transgenic models has suggested a functional complexity of β 2 AR beyond its regulation of LCC Ca 2+ influx. It has been reported that β 2 AR activation blunts β 1 AR signaling in failing heart cells. 20 In transgenic mice overexpressing β 2 AR, cardiomyocyte contractility is upregulated by spontaneous β 2 AR-cAMP signaling but is no longer able to respond to β 1 AR stimulation. 21, 22 Recently, the epinephrine-induced Takotsubo cardiomyopathy characterized by apical depression of myocardial contraction has been attributed to β 2 AR signaling. 23 On the basis of these facts, we hypothesized that β 2 AR activation may exert an inhibitory regulation on β 1 AR signaling. In the present study, we tested this hypothesis and found that selective β 2 AR activation compartmentalizes β 1 AR signaling into nanoscopic submembrane microdomains by way of β 1 AR C terminus (β 1 CT)-dependent recruitment of PDEs.
Methods
Detailed Methods are available in the Online Data Supplement. The authors declare that all supporting data are available within the article and its online supplementary files. Further information of this study is available from the corresponding author upon reasonable request.
Animals
Animal experiments were approved by the Institutional Animal Care and Use Committee of Peking University. To avoid any sexual hormone effects on adrenergic receptors, male animals were used at the age of 8-12 weeks. A β 1 AR knockin rat was generated using CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-CRISPR-associated protein 9) technology, with the serines at positions 461, 462, and 464 mutated to alanines. Homozygous knockin rats were used for experiments.
Patch Clamp and Confocal Ca 2+ Imaging
Single ventricular myocytes from adult male rats or mice were enzymatically isolated as previously described. 8 Experiments combining patch-clamp analyses and confocal imaging were performed on an EPC7 amplifier and an LSM-510 confocal microscope. 8 Fluo-4 pentapotassium salts were included in the microelectrode to measure whole-cell Ca 2+ signals.
β-Arrestin-1 and β 1 AR C Terminus Binding Assay
The GST (glutathione S-transferase) prokaryotic expression vectors of wild-type or mutated β 1 AR C terminus were transformed to Rosetta competent cells. After sonication and centrifuging, the supernatant containing β 1 AR C terminus was added to GST-tagged 
Novelty and Significance
What Is Known?
• β 1 AR (β 1 -adrenergic receptor), by coupling to G s (stimulatory G protein), mediates global regulation of both L-type Ca 2+ channels in sarcolemma/T tubules and RyR (ryanodine receptor) Ca 2+ release channels in SR (sarcoplasmic reticulum).
• β 2 AR, which couples both G s and G i (inhibitory G protein) and recruits phosphodiesterase-4 to sarcolemma/T tubules, mediates compartmentalized signaling with little effect on SR Ca 2+ uptake.
What New Information Does This Article Contribute?
• β 2 signaling intrudes into β 1 pathway, converts β 1 signaling from global to compartmentalized mode. • This offside compartmentalization requires β 2 AR-mediated modification of β 1 AR C terminus and involves G protein-coupled receptor kinase-2, β-arr1 and phosphodiesterase-4.
• The compartmentalization is of nanoscale, preventing βARs (β-adrenergic receptors) from phosphorylating RyRs nanometers away from sarcolemma/T tubules.
βARs play pivotal roles in sympathetic regulation of cardiovascular function. It is known that activation of β 1 ARs, but not β 2 ARs, robustly enhances Ca 2+ transient and contraction in heart cells. This is because the cAMP signal activated by β 2 AR agonist is confined within a submembrane domain without reaching the SR Ca 2+ uptake/release apparatuses. In the present study, we found that, when β 2 and β 1 ARs are activated simultaneously or successively, β 2 signaling intrudes into the β 1 pathway. By modifying the C terminus of β 1 AR, β 2 signaling compartmentalizes the otherwise global β 1 signal into nanoscopic submembrane domains, keeping catecholamine from regulating intracellular Ca 2+ transient and heart contraction. Because circulating epinephrine preferentially activates β 2 ARs in cardiomyocytes, this offside compartmentalization provides a novel negative feed-forward mechanism to curtail the β 1 signal cascade that would otherwise cytotoxically sustain due to circulating catecholamine. This suppressive background then enables a sharpened cardiac response when β 1 ARs are dominantly activated by synaptic norepinephrine during sympathetic nerve excitation.
Immunocytochemistry
Cardiomyocytes were fixed in 4% paraformaldehyde for 20 minutes, permeabilized with 0.3% Triton X-100 for 20 minutes, and blocked with 10% goat serum in PBS for 1 hour at 37°C. The samples were then incubated with primary antibodies against GRK2 and phosphorylated RyR2 overnight and with a DyLight488-conjugated secondary antibody for 1 hour. After the final washes, the cells were mounted and sealed for imaging.
Immunoelectron Microscopy
The RyR2 immunoelectron microscopy labeling was performed as described. 24 After fixation and permeabilization, the samples were incubated with primary antibodies overnight and 1.4 nm immunogold-conjugated secondary antibody for 1 hour, with the gold particles enhanced by HQ SILVER enhancement kit (Nanoprobes). After fixation in 0.1% OsO 4 in 0.1 mol/L cacodylate buffer, the samples were dehydrated, embedded, and polymerized. The thin sections (80 nm) were stained with 2% uranyl acetate for 10 minutes and counterstained with lead citrate.
Statistics
All data are reported as mean±SEM, with the SEM indicated by the error bars. Where appropriate, Student t test, rank-sum test, or HolmSidak test following the 2-way ANOVA with repeated measures was applied to determine statistical differences. P <0.05 was considered statistically significant. transients, was significantly increased ( Figure 1A ; gray circles in Figure 1B ). This result agrees well with and can be fully explained by typical β 2 AR signaling. However, when the salbutamol concentration was increased to 50 μmol/L, the Ca 2+ transient amplitude evoked by depolarizations to −10 to 40 mV was still not changed (black circles in Figure 1B ). Only when β 2 AR was blocked using 0.5 μmol/L ICI118551 (ICI; Sigma-Aldrich, St Louis, MO), a selective β 2 AR antagonist, did 50 μmol/L salbutamol upregulate the Ca 2+ transients at −10 to 40 mV, which were then eliminated by addition of 0.3 μmol/L CGP20712A, a selective β 1 AR antagonist (Online Figure I ). These results indicated that a high concentration of salbutamol cannot generate a typical effect of β 1 AR activation except when β 2 AR is blocked.
Results
Isoproterenol is a βAR agonist with K d s of 0.87 and 0.23 μmol/L for β 1 AR and β 2 ARs, respectively. 25 Although it is well known that 1 μmol/L isoproterenol alone is able to increase both I Ca and Ca 2+ transient amplitude ( Figure 1A ; gray circles in Figure 1C ), the presence of salbutamol prevented isoproterenol from regulating Ca 2+ transients at −10 to 40 mV ( Figure 1A ; black circles in Figure 1C ), indicating that β 1 AR signaling was compromised after β 2 AR activation.
Because both β 1 AR and β 2 ARs are able to regulate LCCs, there are 2 possible explanations for the salbutamol-suppressed β 1 effect on Ca 2+ transients: (1) β 1 AR signaling is totally paralyzed by β 2 AR activation, and the upregulated LCC I Ca is attributable to β 2 AR signaling; or (2) β 1 AR signaling is compartmentalized to a submembrane local domain, where the cAMP signal regulates LCC without reaching the SR proteins. To discriminate between these 2 possibilities, we perfused cardiomyocytes with salbutamol for 5 minutes before switching to a test solution without salbutamol ( Figure 1D ). When the test solution contained 0.5 μmol/L ICI and 1 μmol/L isoproterenol to stimulate β 1 AR, the I Ca evoked by a depolarization from −70 mV to 0 mV was significantly higher than in cardiomyocytes treated with ICI alone (Figure 1E left, white and dark gray dots), indicating that β 1 AR was still able to regulate LCCs after salbutamol pretreatment. However, under this condition, the Ca 2+ transient still did not respond to ICI+isoproterenol ( Figure 1E right, white and dark gray dots), indicating that the β 1 AR signal, which would otherwise increase Ca 2+ transients without salbutamol pretreatment, was confined to an LCC-residing local domain without reaching the SR Ca 2+ handling proteins. In cardiomyocytes, PDE4 plays an important role in compartmentalizing βAR signaling and heterologous desensitization among GPCRs (G protein-coupled receptors). [17] [18] [19] We therefore tested the effect of a PDE4 inhibitor, rolipram, and found that isoproterenol increased I Ca and also upregulated the amplitude of Ca 2+ transients at 0 mV in the presence of rolipram ( Figure 1F ; gray and black dots in Figure 1E ). Although it is well known that β 2 AR signaling per se is compartmentalized 9,12 (onside compartmentalization), it is surprising to find that β 2 AR signaling is able to extend the PDE4-containing hedge to β 1 AR, converting β 1 AR signaling from a global to a compartmentalized mode (offside compartmentalization).
β 2 AR Signaling Targets β 1 CT
In cardiomyocytes, PDE4 molecules are usually recruited by β-arrs to the C terminus of βARs that are phosphorylated by GRKs (GPCR kinases). [17] [18] [19] We therefore sought to knock down the key players in this process in cultured rat cardiomyocytes to assess the pathway influencing the β 2 -induced offside compartmentalization of β 1 AR. However, we found that the offside compartmentalization no longer existed in cultured cells (Online Figure II) , precluding the application of cell culture-based experiments for exploring the involved mechanisms. As such, our strategy was to explore the pathway via pharmacological methods and to test our conclusions using a genetic knockin model.
To determine whether β 1 CT was involved in the offside compartmentalization, we designed cell-permeable interfering peptides against rat β 1 CT (wild-type β 1 CTs [WCT], Figure 2A upper), which itself did not influence Ca 2+ transients in the presence of salbutamol (Online Figure III) . We found that the 1 μmol/L WCT peptide successfully rescued the effect of isoproterenol on Ca 2+ transients at 0 mV ( Figure 2B ). However, when the sequence containing the last 3 serine residues was deleted from the WCT peptide (truncated C-terminus of β 1 -adrenergic receptor [ΔCT], Figure 2A ), the truncated peptide was no longer able to rescue the effect of isoproterenol ( Figure 2B ), suggesting that the deleted sequence of β 1 CT might be required for the offside compartmentalization.
To determine whether the offside compartmentalization involved an interaction between β 1 CT and β-arrs, we synthesized interfering peptides containing the βAR-interacting domains of βarr1 and βarr2 (β-arrestin-2) (Online Figure  IVA) , which themselves did not influence Ca 2+ transients in the presence of salbutamol (Online Figure IVB) . We found that loading 1 μmol/L βarr1, but not βarr2, into the pipette 2+ transient amplitudes in Salb+Iso groups without or with βarr (β-arrestin) interfering peptides βarr1 and βarr2. Data in each group were from 6 to 9 cells sampled in 3 to 4 rats. *P<0.05 vs Salb+Iso determined by Holm-Sidak test following the 2-way ANOVA with repeated measures. D, Representative blot from GST pulldown assays for β-arr1 and β 1 CT. In WCT, S-A and S-E groups, GST was tagged with wild-type and mutated β 1 CTs, whose sequences are shown in A. E, The ratio of precipitated β-arr1 with respect to loaded GST-β 1 CT. N=3. *P<0.05 vs WCT determined by t test with Bonferroni correction. F, Ca 2+ transient amplitudes in Salb+Iso groups without or with the GRK2 (GPCR kinases) inhibitor GRK2i. Data in each group were from 6 to 7 cells sampled in 5 rats. *P<0.05 vs Salb+Iso determined by Holm-Sidak test following the ANOVA with repeated measures.
solution successfully rescued the isoproterenol response of Ca 2+ transients at 0 mV in salbutamol-treated cardiomyocytes ( Figure 2C ), suggesting that β-arr1 was involved in the offside compartmentalization. In accordance, GST pull-down assays showed that the interaction between β 1 CT and β-arr1 was enhanced when the serines of β 1 CT were substituted with glutamates (S-E in Figure 2A ) to mimic phosphorylation, but this interaction was unchanged when the substitution consisted of alanines (S-A in Figure 2A and 2D through 2E) .
By phosphorylating the C terminus of βARs, GRK2 negatively regulates both β 1 AR and β 2 AR signaling in failing heart cells. 26, 27 To test whether GRK2 was required for the offside compartmentalization, we inhibited GRK2 using the specific GRK2 inhibitor GRK2i (100 μmol/L) and found that isoproterenol regained its capability to upregulate Ca 2+ transients at 0 mV in salbutamol-treated cardiomyocytes ( Figure 2F ), suggesting that GRK2 was required for β 2 AR-mediated offside compartmentalization of β 1 signaling.
In agreement with this finding, we observed that GRK2 became striated upon salbutamol stimulation ( Figure 3A) , as indexed by the increased signal power at the spatial frequency of ≈0.58 μm −1 ( Figure 3B and 3C). Similar phenomenon was observed ( Figure 3D ) when β 2 AR was stimulated with 0.1 μmol/L zinterol (with K d s of 1.1 and 0.0091 μmol/L for β 1 AR and β 2 AR, respectively 25 ). The colocalization of GRK2 signals with caveolin-3 signals suggested that GRK2 was recruited to sarcolemma/TT membranes ( Figure 3D ). This GRK2 trafficking was exclusively caused by β 2 AR activation, as GRK2 trafficking did not occur in the presence of 0.5 μmol/L ICI no matter whether salbutamol ( Figure 3C ) or isoproterenol ( Figure 3E ) was applied. In mouse models, the GRK2 trafficking was induced by β 2 AR stimulation in wild-type cardiomyocytes but not in β 2 AR-knockout cells ( Figure 3F and 3G). However, it did occur in cardiomyocytes from β 1 AR-knockout mice ( Figure 3H ). 
Offside Compartmentalization Is Eliminated in Knockin Rats With Mutant β 1 CT
On the basis of the results in Figure 2A through 2E, we inferred that the offside compartmentalization of β 1 AR would be eliminated if we mutated the related serine residues of β 1 CT. We therefore created a knockin rat model in which each of the last 3 serine residues was replaced by a nonphosphorylatable alanine (SAKI; Figure 4A ). Echocardiographic measurements showed that this mutation did not change the parameters of cardiac function in vivo (Online Figure V) . Biochemical and cellular characterizations showed that the location ( Figure 4B  and 4C ) and protein level ( Figure 4D ) of β 1 AR were comparable in wild-type and SAKI cardiomyocytes, indicating that the mutation did not change the expression of β 1 AR.
In wild-type and SAKI rat cardiomyocytes, we applied 2 pairs of βAR agonists (zinterol/salbutamol for β 2 AR stimulation, and norepinephrine/isoproterenol for testing β 1 AR response) to demonstrate that the offside compartmentalization was a general interaction between β 1 ARs and β 2 ARs. In wildtype cardiomyocytes, 0.1 μmol/L zinterol did not modulate Ca 2+ transients, but it was able to induce GRK2 trafficking ( Figure 4E transients to the same extent as norepinephrine did in SAKI cardiomyocytes ( Figure 5B lower) . Similarly, isoproterenol became able to regulate Ca 2+ transients in the presence of salbutamol in SAKI cardiomyocytes (Online Figure VI) . These results indicated that β 2 AR stimulation was no longer able to compartmentalize β 1 AR signaling without the 3 phosphorylatable serine residues of the β 1 CT. Ca 2+ sparks are elementary events of RyR Ca 2+ release. To probe the microscopic aspect of the offside compartmentalization, we analyzed the βAR response of Ca 2+ sparks ( Figure 5C ), which reflected the modulation of RyRs. 8 In both wild-type and SAKI cardiomyocytes, 0.1 µmol/L norepinephrine, but not 0.1 μmol/L zinterol, significantly increased Ca 2+ spark amplitude ( Figure 5D ). However, in the presence of zinterol, norepinephrine was no longer able to modulate spark amplitude in wild-type cardiomyocytes, in good agreement with the offside compartmentalization observed in whole-cell Ca 2+ transients. In contrast, norepinephrine was fully functional in upregulating Ca 2+ spark amplitude regardless of the existence of zinterol in SAKI cells.
βAR Signaling Is Compartmentalized in a Nanoscale Local Domain
In wild-type cardiomyocytes, the inability of norepinephrine to modulate Ca 2+ spark amplitude in the presence of zinterol suggested that β 2 AR stimulation might prevent β 1 AR signaling from modulating RyRs, which are only nanometers away from the sarcolemma/TT membrane. To test this possibility directly, we next measured RyR phosphorylation using an antibody that recognized the PKA-dependent phosphorylation of serine 2809 (S2809, Figure 6A and Online Figure VII) .
In wild-type cardiomyocytes, immunocytochemical ( Figure 6B and 6C) and biochemical (Online Figure VIII) analysis showed that the RyR phosphorylation level in norepinephrine-treated cardiomyocytes was significantly higher than in zinterol-treated cells. Similarly, isoproterenol induced higher-level RyR phosphorylation than salbutamol (Online Figure IX) , agreeing well with the report that β 2 AR signaling does not significantly alter the phosphorylation of S2809 of RyRs. 28 However, in the presence of zinterol/salbutamol, norepinephrine/isoproterenol was no longer able to increase the S2809 phosphorylation level ( Figure 6C , Online Figures  VIII and IX) , although they still upregulated LCCs. This result confirmed that a signaling hedge was indeed formed between β 1 ARs/LCCs and RyRs during β 2 AR activation. On the basis of recent structural biological studies, 29 the S2809 phosphorylation sites reside on the top of the ≈13-nm height cytosolic domain of RyR, implying that the S2809 site is only 2 to 4 nm away from the sarcolemma/TT membrane ( Figure 6D ). Even considering that β 1 ARs/LCCs are not aligned with RyRs in most cases, the β 2 AR-mediated offside compartmentalization must occur on the nanoscale to distinguish LCCs from RyRs.
In SAKI cardiomyocytes, the effects of norepinephrine and zinterol alone were similar to those in wild-type cardiomyocytes. However, when they were applied together, zinterol was no longer able to interfere with norepinephrine-induced RyR phosphorylation ( Figure 6C, Online Figures VIII and  IX) . These results indicated that the nanoscale offside compartmentalization could not be established without the phosphorylatable serine residues of β 1 CT.
Discussion
As the major mechanism of sympathetic regulation of cardiac excitation-contraction coupling, acute βAR signaling increases the Ca 2+ trigger for Ca 2+ -induced Ca 2+ release by increasing the open probability of LCCs, 10 accelerates the RyR response to Ca 2+ triggers by sensitizing RyRs, 8 and elevates the loading of releasable Ca 2+ in the SR by dispelling phospholamban inhibition from SERCA. 5 Among these processes, localized β 2 AR signaling only regulates LCCs (but not in mice 11 ), whereas global signaling of β 1 ARs regulates LCC, RyR, and SERCA activities. 14 In the present study, we demonstrated that local β 2 AR signaling converted β 1 AR signaling from global to local mode, preventing β 1 ARs from regulating RyRs nanometers away from sarcolemma/TTs. In this offside nanoscale compartmentalization, β 2 AR targeted serine residues of β 1 CT via GRK2, and in turn compartmentalized β 1 AR signaling in a PDE4-dependent manner. β 1 AR and β 2 AR are the major βAR subtypes, accounting for ≈80% and 20% of the total cardiac βARs, respectively. 30, 31 A recent single-cell mRNA analysis suggested that β 2 AR is only expressed in a small percentage of cardiomyocytes 32 ; however, this suggestion contradicts most functional studies. For example, although β 2 AR agonists that activate both G s and G i pathways do not influence SR Ca 2+ release, many studies have shown that G s -biased β 2 AR agonists, such as fenoterol, robustly regulate SR Ca 2+ release in cardiomyocytes. 33 Given the limitations of current quantitative reverse transcription polymerase chain reaction technology in detecting low-level mRNA expression, 34 single-cell mRNA results may not be completely reliable in this case. In the present study, β 2 AR expression in most (if not all) cardiomyocytes is supported by the following facts: (1) The β 2 AR agonists salbutamol and zinterol prevented β 1 AR from phosphorylating RyRs and from regulating Ca 2+ transients and Ca 2+ sparks, which would not be possible if salbutamol and zinterol acted on only a small fraction of cardiomyocytes. (2) An excessive dose of salbutamol was able to activate β 1 AR only when β 2 AR was blocked, and this blockage would not be necessary if β 2 AR was mostly absent. (3) Salbutamol-induced GRK2 trafficking was robust in β 1 AR-knockout cardiomyocytes, but it was eliminated after ICI treatment. These observations reinforced the long-established notion that β 2 AR is expressed in most (if not all) cardiomyocytes, which is a prerequisite for discussing the mechanisms of offside compartmentalization.
Although β 1 AR and β 2 AR coexist in cardiomyocytes, their spatial distribution differs. Whereas β 1 AR is expressed globally in sarcolemma/TTs, β 2 AR usually resides in caveolae. 15 Recently, it has been shown that the compartmentalization of β 2 AR signaling depends on caveolin-3, 16, 28 and caveolin-3 exists in the TT-SR junctions and interacts with an SR transmembrane protein, junctophilin-2. 35, 36 Amino acid sequence analysis shows that junctophilin-2 contains a caveolin-3-binding domain 37 in its N-terminal sequence. As junctophilin-2 is a trans-SR protein interacting with sarcolemma/TTs, it is possible that caveolin-3, together with cholesterol and scaffold proteins, organizes a local signaling environment for βARs, G proteins, PDEs, and LCCs within the TT-SR junctional area. This scenario would adeptly explain why β 2 AR stimulation regulated LCCs but prevented β 1 AR signals from regulating RyRs.
In the presence of a β 2 AR agonist, the inability of βARs (including β 1 AR and β 2 AR) to phosphorylate RyRs suggested that the signaling territory of each βAR is no larger than 10 −22 Figure 6 . Immunocytochemical analysis of RyR (ryanodine receptor) phosphorylation in wild-type (WT) and SAKI rat cardiomyocytes. A, Immunoelectron microscopy of RyR phosphorylation labeled using an antibody that recognizes the RyR phosphorylation at p-RyR2 gold particles (green arrow heads) and unphosphorylated RyR2 electron densification (blue arrow heads) were present around the T tubules (TTs). Their positioning discrepancy was illustrated in Online Figure VII . Scale bar, 100 nm. B, Representative immunocytochemical imaging of S2808-phosphorylated RyRs. Scale bar, 30 μm. C, Quantification of phosphorylation levels in WT and SAKI cardiomyocytes. Data in each group were from 30 cells sampled in 3 rats. **P<0.01vs Control determined by t test with Bonferroni correction. D, Schematic illustration of the positioning of the S2809 sites in RyR2. The RyR structure was generated based on published RyR2 structure data. 29 NE indicates norepinephrine; SR, sarcoplasmic reticulum; and Zin, zinterol.
or 10 −19 L, depending on whether βARs reside in or out of the TT-SR junctional area. Previously, the local signaling of β 2 AR is supported by the observations that LCCs under a microelectrode pipette could not be modulated by β 2 AR stimulation outside of the pipette 10 and that β 2 AR cannot phosphorylate phospholamban, 12 which usually resides in the longitudinal SR. As both the diameter of a microelectrode tip and the distance between longitudinal SRs and TTs are on the micron scale, the estimated signaling microdomain of a β 2 AR was <1 μm 3 (10 −15 L). Therefore, our data suggested that the localized β 2 AR signaling territory, or nanodomain, should be 4 to 7 orders of magnitude smaller than previous estimations. Moreover, the stimulation of β 2 AR compartmentalizes the β 1 AR signals to the same size (10 −22 to 10 −19 L) nanodomain. Different isoforms of PDE play important roles in compartmentalizing GPCR signaling. 18, 38 Although the recruitment of PDE4D5 is a key event in compartmentalizing β 2 AR-cAMP signaling, PDE4D8 detaching from the PDZ domain of β 1 CT is essential for allowing global β 1 AR-cAMP signaling. 17, 18 In the present study, we found that the β 1 AR compartmentalization induced by β 2 AR activation was eliminated by the selective PDE4 inhibitor rolipram, indicating that PDE4 is involved in the offside compartmentalization. However, different from the heterologous desensitization, where the PDE4 recruitment of PDE4 depends on β-arr2, 19 the offside compartmentalization involved β-arr1. Given that cell culture-based methods could not be used to study the offside compartmentalization, it has not yet been determined whether β 2 AR promotes the recruitment of PDE4D5 to β 1 AR or reinforces PDE4D8 binding to β 1 AR. Our immunocytochemical experiment supported PDE4D5 was mobilized by β 2 AR stimulation (Online Figure X) . PDE4D recruitment depends on β-arr1 and phosphorylation of the βAR C terminus. Indeed, a knockin rat model harboring the mutant β 1 AR, where the last 3 serine residues were replaced by nonphosphorylatable alanine residues, did not exhibited the offside compartmentalization of β 1 AR, although their β 2 AR signaling pattern (ie, increased I Ca and unchanged Ca 2+ transients) was not changed. Notably, the replacement of serines did not cause a detectable change in GRK2-β 1 AR binding (Online Figure XI) , suggesting that the offside compartmentalization pathway was blocked because of the absence of phosphorylated residuals rather than altered GRK2-β 1 AR binding. Taken together, experiments on this genetic model provided firm evidence that β 2 AR signaling indeed targeted β 1 AR to exert the offside compartmentalization. On the basis of these findings, we have updated the signaling diagram of β 1 ARs, as presented in Online Figure XII. Besides PDE4, G i is another key player in compartmentalized signaling of β 2 AR. 13, 14 Upregulated GRK2 has been shown to enhance β 2 AR phosphorylation in failing heart cells, leading to G i -biased β 2 AR signaling. 39 Activation of insulin receptors has also been found to phosphorylate β 2 AR, which in turn promotes β 2 AR coupling to G i . 40 In the present study, we showed that β 2 AR activation compartmentalized β 1 ARs in a GRK2-dependent manner. It is thus an intriguing question whether GRK2-phosphorylated β 1 ARs become able to couple the G i pathway. It is also reported that chronic β 1 AR/β 3 AR stimulation suppresses β 1 AR signaling through a regulation involving phosphoinositide 3-kinase and p38 mitogen-activated protein kinase. 41 Therefore, the molecular mechanism of the offside compartmentalization might be more complex than we proposed based on current evidence. Nevertheless, our results with the SAKI rat are more compelling to say that the modification of the β 1 AR C terminus is the key mechanism among other possibilities.
Importantly, the offside compartmentalization can be activated in vivo by epinephrine, preventing norepinephrine from regulating heart contraction (Online Figure XIII) .Epinephrine is an adrenal hormone with a weak selectivity toward β 2 AR over β 1 AR, 25 whereas norepinephrine is a sympathetic neurotransmitter mainly activating β-and α 1 ARs. 42 Given that epinephrine and a smaller amount of norepinephrine are secreted tonically from the adrenal glands 23 and that tonic activation of β 1 AR is cytotoxic, 43, 44 offside compartmentalization may provide a negative feed-forward mechanism both to avoid tonic cytotoxicity of circulating catecholamine and to sharpen the transient response of β 1 AR to norepinephrine upon sympathetic excitation. Pathological or defective offside compartmentalization may result in an impaired sympathetic response, as seen in certain heart failure situations, 45 or lead to increased cytotoxicity and cell death, as occurs in β 2 AR knockout mice. 46 Therefore, the signaling cascade prompting the offside compartmentalization provides many potential novel targets for drug discovery against cardiovascular diseases.
